ALBENVET 360 (tablets)

Round tablets, white to light grey in colour.

1 tablet (1,8 g) contains active substance:

- albendazole – 0,36 g.

Excipients: potato starch, lactose, calcium stearate, talc.

ATCvet QP52, antiparasitic veterinary medicinal products (QP52AC11, albendazole).

The active substance of the product, albendazole, belongs to the group of benzimidazoles.

The mechanism of action of albendazole consists in inhibition of protein (tubular) synthesis, resulting in impairment of uptake and intracellular transport of nutrients, disturbance of substrate metabolism (adenosine triphosphate (ATP) and glucose), as well as a decrease of mitochondrial reactions through inhibition of fumarate reductase, which leads to a reduction of glycogen stores and death of parasites from exhaustion.

Albendazole also has an ovocidal effect (destroys helminth eggs), decreases contamination of pastures and dog walking areas with helminths, and reduces the probability of reinfestation of animals.

Albendazole is administered to animals without fasting and without the use of laxatives.

The pharmacokinetics of albendazole in cattle, dogs and cats is poorly characterised. It is considered that, when administered orally, the product is absorbed better than other benzimidazoles. Approximately 47% of the dose administered orally is excreted in the urine as metabolites within 9 days.

Treatment and prevention in cattle, sheep, goats, horses, dogs and cats of invasive diseases caused by adult and larval forms of nematodes of the gastrointestinal tract and respiratory tract, cestodes and trematodes:

- nematodes of the gastrointestinal tract: Haemonchus spp., Bunostomum spp., Ostertagia spp., Trichostrongylus axei, T. colubriformis, Cooperia spp., Oesophagostomum spp., Nematodirus spp.;

- nematodes of the respiratory tract: Dictyocaulus viviparus, Dictyocaulus filaria;

- cestodes: Moniezia expansa, M. benedeni, Thysaniesia giardi;

- trematodes: Fasciola hepatica (adult forms), Dicrocelium lanceatum;

- nematodes of the gastrointestinal tract: Parascaris equorum, Strongylus vulgaris, S. equinus, Oxyuris equi;

- nematodes of the gastrointestinal tract: Toxocara spp., Toxascaris spp., Ancylostoma spp., Uncinaria spp., Trichuris spp.,

- cestodes: Taenia spp., Dipylidium caninum, Diphyllobothrium latum;

- trematodes: Opisthorchis felineus.

Administered as a single oral dose with feed, without fasting, at the following doses:

Hypersensitivity to substances of the benzimidazole group.

Do not administer to animals with diseases of the liver, kidneys and haematopoietic system!

Do not administer to weakened and emaciated animals!

Do not administer simultaneously with other anthelmintic medicinal products!

Do not administer in cases of acute fasciolosis!

The product must not be administered during mating, to female animals in the first trimester of pregnancy, and to ewes in the first half of pregnancy!

Slaughter of animals for meat is allowed 14 days after the last administration of the product. Milk may be used for human consumption after 2 days.

Before the specified withdrawal periods, milk and meat shall be fed to non-productive animals or disposed of in accordance with the opinion of a veterinary surgeon.

When working with the product, general rules of personal hygiene and safety rules for work with veterinary medicinal products must be observed.

Bags made of polyethylene, polyvinyl chloride or polyethylene terephthalate film containing 1 tablet.

Polymer containers containing 10 and 100 tablets.

Store in the original package, in a dry, dark place out of  the  reach of  children,  at  a   temperature   from 10 °C to 25 °C.

1 year.